EXPE
83
8
GD
42
4
STZ
42
2
ES
12
3
OMC
37
2
UPS
51
6
EXPD
29
2
CAG
34
3
GILD
55
5
IR
46
3
R
55
-2
BK
60
2
MAC
53
5
ADP
57
2
HUM
25
4
HSY
32
3
BXP
39
5
ADT
12
2
ROP
44
6
NTRS
35
10
EXPE
83
8
GD
42
4
STZ
42
2
ES
12
3
OMC
37
2
UPS
51
6
EXPD
29
2
CAG
34
3
GILD
55
5
IR
46
3
R
55
-2
BK
60
2
MAC
53
5
ADP
57
2
HUM
25
4
HSY
32
3
BXP
39
5
ADT
12
2
ROP
44
6
NTRS
35
10
Financhill
Back

Verona Pharma PLC Quote, Financials, Valuation and Earnings

The AI Energy Miracle

Details Here.
Sell
42

VRNA
Verona Pharma PLC

Last Price:
$42.08
Seasonality Move:
-1.61%

7 Day Trial

ALL ACCESS PASS

$ 7

How to Turn the AI Energy Crisis into BIG Profits

And investors who move now into one technology could make a whole lot of money.

Verona Pharma PLC Price Quote

$42.08
+0.02 (+2.09%)
(Updated: December 21, 2024 at 5:53 AM ET)

Verona Pharma PLC Key Stats

Sell
42
Verona Pharma PLC (VRNA) is a Sell
Day range:
$40.10 - $42.86
52-week range:
$11.39 - $43.73
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
26.38%
Volume:
733.6K
Avg. volume:
1M
1-year change:
153.68%
Market cap:
$3.4B
Revenue:
$0
EPS:
$-2

How Much Does Verona Pharma PLC Make?

Data Unavailable

Is Verona Pharma PLC Growing As A Company?

Data Unavailable

Verona Pharma PLC Stock Price Performance

What Is Verona Pharma PLC 52-Week High & Low?

Verona Pharma PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Verona Pharma PLC?

Data Unavailable

Is Verona Pharma PLC Cash Flow Positive?

Data Unavailable

Verona Pharma PLC Return On Invested Capital

Data Unavailable

Verona Pharma PLC Earnings Date & Stock Price

Verona Pharma PLC Competitors

  • Who Are Verona Pharma PLC's Competitors?
    Below is a list of companies who compete with Verona Pharma PLC or are related in some way:
    • Adaptimmune Therapeutics PLC (ADAP)
    • Autolus Therapeutics PLC (AUTL)
    • Biodexa Pharmaceuticals PLC (BDRX)
    • DBV Technologies SA (DBVT)
    • TC BioPharm (Holdings) PLC (TCBP)

Verona Pharma PLC Dividend Yield

Data Unavailable

Verona Pharma PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -36.59%
Revenue: 0% 180.53%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 47.29
Upside from Last Price: 12.42%

Major Shareholders

Data Unavailable